Showing 2,829 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP policies & guidelines

England: Building on the PrEP victory

Editor's pick
The Lancet (editorial)
27 March 2020
PrEP programmes & uptake

Supporting PrEP in eastern Europe and central Asia

News
26 March 2020
Hepatitis B

HIV PrEP also prevents hepatitis B – and works better than the hepatitis B vaccine

News
26 March 2020
PrEP science

Older age and baseline kidney function are the key risk factors for renal dysfunction while taking HIV PrEP

News
23 March 2020
PrEP science

F/TAF and F/TDF Efficacy and Safety as PrEP for 96 Weeks

Editor's pick
NATAP
20 March 2020
PrEP science

Diagnostic challenges with PrEP use during early HIV infection

News
18 March 2020
PrEP policies & guidelines

UNAIDS welcomes government’s decision to make PrEP routinely available across England

Editor's pick
UNAIDS
17 March 2020
PrEP policies & guidelines

Statement in response to the Department of Health and Social Care fully-funding roll out of PrEP

Editor's pick
Sophia Forum
16 March 2020
PrEP policies & guidelines

HIV drug PrEP to be available across England

Editor's pick
Department of Health and Social Care
16 March 2020
PrEP policies & guidelines

PrEPster applauds England PrEP decision

Editor's pick
Prepster
15 March 2020
PrEP policies & guidelines

Statement in response to Department of Health and Social Care fully-funding roll-out of PrEP

Editor's pick
National AIDS Trust
15 March 2020
Transgender people

Unique transgender vulnerabilities require tailored and specific interventions

News
13 March 2020
PrEP science

Taking PrEP during acute HIV infection for more than 2-3 weeks is likely to cause resistance, Thai study finds

News
13 March 2020
PEP

New PEP studies revive interest in post-exposure prevention

News
11 March 2020
PrEP science

NIH study finds lower concentration of PrEP drug in pregnant teens & young women

Editor's pick
National Institutes of Health
10 March 2020
Undetectable viral load & treatment as prevention

HIV incidence fell by three-quarters in Australian gay men, with strong association with treatment as prevention

News
10 March 2020
PrEP policies & guidelines

Far fewer people would get PrEP in the US if generic TDF/FTC is replaced with Descovy (TAF/FTC), cost-effectiveness study finds

News
9 March 2020
PrEP science

Uptick in Statin Use After Descovy in HIV PrEP

Editor's pick
Medscape (requires free registration)
9 March 2020
PrEP programmes & uptake

First African study offering PrEP to the general population finds that about a quarter of people at high HIV risk start it

News
6 March 2020
Bad science & bogus treatments

They’re Still Here! Scary HIV Ads on Facebook Won’t Go Away

Editor's pick
POZ
5 March 2020
PrEP programmes & uptake

How are PEPFAR Countries Implementing PrEP?

Editor's pick
Contagion Live
5 March 2020
PrEP programmes & uptake

How Telehealth Platforms Make It Easy to Get PrEP

Editor's pick
TheBody
26 February 2020
PrEP policies & guidelines

England: Charity questions readiness for PrEP to be routinely available by April 2020

Editor's pick
Pharmaceutical Journal
26 February 2020
PrEP programmes & uptake

Overcoming barriers to PrEP: Program models using diverse settings and providers

Editor's pick
CATIE
26 February 2020